Skip to main content

Table 1 Baseline characteristics of all 118 patients

From: Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy - Long-term results

Age median/range (years)

64/30 - 84

Female/male no.

35/83

Clinical tumor stage no. (%)

 

cT2

11 (9.3)

cT3

106 (89.3)

cT4

1 (0.8)

Clinical nodal stage no. (%)

 

Node negative

60 (50,8)

Node positive

54 (45.8)

Unknown

4 (3.4)

Clinical UICC stage no. (%)

 

II

59 (50)

III

49 (41.5)

IV

10 (8.5)

Tumor location no. (%)

 

Upper third of rectum

10 (8.5)

Middle third of rectum

59 (50)

Lower third of rectum

49 (41.5)